The U.S. Supreme Court is poised to determine whether the abortion pill mifepristone will continue to be broadly available in the United States as it weighs a bid by Democratic President Joe Biden’s administration to defend the drug in a challenge to its regulatory approval by anti-abortion groups.
Posts
Use of the drug misoprostol on its own to terminate pregnancies is on the rise in the United States as providers seek a preemptive alternative while a ban on abortion pill mifepristone is being considered in court.
The White House is planning to re-up discussions with abortion pill manufacturers and U.S. pharmacy chains on ways to push back against efforts to ban mifepristone, two sources with knowledge of the matter said, as it appeals a Texas court ruling suspending the approval of the drug.
These are the first lawsuits of their kind since the U.S. Supreme Court overturned the federal constitutional right to abortion.
The U.S. Food and Drug Administration on Friday changed the label for the emergency contraception known as Plan B One-Step to make clear that the pill does not alter the course of an existing pregnancy.
Six months after the U.S. Supreme Court overturned its 1973 Roe v. Wade ruling, the state of abortion rights around the country remains unsettled, thanks to a patchwork of lawsuits in state courts and emergency court orders.
With reproductive rights under attack and professional and personal challenges escalated as a result of the pandemic, women have been collectively called on to lead with not just authenticity, but also with compassion, kindness, and empathy. “In times of crisis, women take center stage. We are the peace makers, the solution seekers, the voice amplifiers,” said HBA interim CEO Wendy White at the 2022 HBA Annual Conference.
With West Virginia’s 1849 abortion ban tied up in court and its conservative legislature stymied over details of enacting a new one, the state’s only abortion clinic ought to be operating as usual.
Federal regulation of data privacy and security has been on the back burner for the past two years, but key members of Congress have been working behind the scenes to frame bipartisan legislation and the FTC is gearing up. The Supreme Court’s decision overturning Roe v. Wade may put this issue front and center in Congress after the midterms.
President Joe Biden plans to sign a second executive order on Wednesday that asks his health department to consider permitting the use of Medicaid funds for patients who travel out-of-state for abortions.
